Nikhil Lalwani is the Chief Executive Officer of InvaGen, a subsidiary of Cipla Ltd. Nikhil is a seasoned pharmaceutical professional with holistic strategic, operational and commercial experiences. He has a successful track record of designing strategy and achieving impact (top, bottom line and value creation) through focused and relentless execution. He has significant experience across functions (R&D, manufacturing, supply-chain, Commercial) in pharmaceuticals.
He retains a distinctive global outlook having lived and worked in every continent in this world. Prior to Cipla, Nikhil worked with McKinsey & Company and Medtronic. He has a MBA from the Wharton School at the University of Pennsylvania and graduated Summa Cum Laude with a B.S. in Electrical Engineering from the Georgia Institute of Technology in Atlanta.